Gloucester, MA, United States of America

Anthony G Quinn

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Anthony G. Quinn

Introduction

Anthony G. Quinn, an accomplished inventor based in Gloucester, MA, has made significant contributions to the field of medical therapy through his ingenious inventions. With a total of two patents to his name, Quinn’s work primarily focuses on treatments for metabolic disorders.

Latest Patents

Quinn's latest patents showcase his commitment to addressing complex medical challenges. One of his notable innovations is the "Arginine Depletion Therapy for Treatment of GAMT Deficiency - Methods and Compositions Therefor." This invention involves methods for treating GAMT deficiency or guanidino acetate (GAA) toxicity through the administration of an arginine-depleting enzyme. Notably, the therapeutic formulation can include either arginase, arginine deiminase, or a combination of both, and is designed for intravenous or subcutaneous administration.

Another significant development is his patent titled "Method and Composition for Treating Arginase 1 Deficiency." This method aims to rapidly reduce levels of arginine and/or guanidino compounds in subjects suffering from arginase 1 (ARG1) deficiency. Such innovations reflect his dedication to advancing medical treatment options for patients with rare metabolic disorders.

Career Highlights

Throughout his career, Anthony G. Quinn has been associated with reputable companies, including Aerase, Inc. and Immedica Pharma AB. His work at these organizations has underscored his expertise in developing therapeutic solutions in the biotech and pharmaceutical industries.

Collaborations

Quinn has also collaborated with esteemed professionals in his field, including Scott W. Rowlinson and Ann Lowe. These partnerships have undoubtedly enriched his work and contributed to the success of his inventions.

Conclusion

Anthony G. Quinn exemplifies the spirit of innovation in the medical technology sector. With his groundbreaking patents and collaborations, he continues to make a meaningful impact in the treatment of metabolic disorders, paving the way for more effective therapeutic approaches in the healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…